WO2004043368A3 - Sulfonamides - Google Patents
Sulfonamides Download PDFInfo
- Publication number
- WO2004043368A3 WO2004043368A3 PCT/US2003/035357 US0335357W WO2004043368A3 WO 2004043368 A3 WO2004043368 A3 WO 2004043368A3 US 0335357 W US0335357 W US 0335357W WO 2004043368 A3 WO2004043368 A3 WO 2004043368A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- sulfonamides
- urotensin
- antagonists
- pharmaceutical compositions
- relates
- Prior art date
Links
- 229940124530 sulfonamide Drugs 0.000 title abstract 2
- 150000003456 sulfonamides Chemical class 0.000 title abstract 2
- 102000050488 Urotensin II Human genes 0.000 abstract 1
- 108010018369 Urotensin II Proteins 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- HFNHAPQMXICKCF-USJMABIRSA-N urotensin-ii Chemical compound N([C@@H](CC(O)=O)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=2C3=CC=CC=C3NC=2)NC(=O)[C@H](CC=2C=CC=CC=2)NC1=O)C(=O)N[C@@H](C(C)C)C(O)=O)C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)CCC(O)=O)[C@@H](C)O HFNHAPQMXICKCF-USJMABIRSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrrole Compounds (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003295408A AU2003295408A1 (en) | 2002-11-06 | 2003-11-06 | Sulfonamides |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42416202P | 2002-11-06 | 2002-11-06 | |
US42412802P | 2002-11-06 | 2002-11-06 | |
US60/424,162 | 2002-11-06 | ||
US60/424,128 | 2002-11-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004043368A2 WO2004043368A2 (en) | 2004-05-27 |
WO2004043368A3 true WO2004043368A3 (en) | 2004-07-22 |
Family
ID=32314525
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/035357 WO2004043368A2 (en) | 2002-11-06 | 2003-11-06 | Sulfonamides |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003295408A1 (en) |
WO (1) | WO2004043368A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9233956B2 (en) | 2008-05-06 | 2016-01-12 | Novartis Ag | Benzene sulfonamide thiazole and oxazole compounds |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE427748T1 (en) | 2003-09-26 | 2009-04-15 | Actelion Pharmaceuticals Ltd | PYRIDINE DERIVATIVES AND THEIR USE AS UROTENSIN II ANTAGONISTS |
MX2007004293A (en) | 2004-10-12 | 2007-06-18 | Actelion Pharmaceuticals Ltd | 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl- quinolin-4-yl)-urea as crystalline sulfate salt. |
CL2007002097A1 (en) | 2006-07-20 | 2008-01-18 | Smithkline Beecham Corp | Compounds derived from pyrrolidine or morpholine antagonists of urotensin ii; pharmaceutical composition comprising said compounds; and its use to treat congestive heart failure, ischemic heart failure, angina, myocardial ischemia, overactive bladder, asthma and / or copd, among others. |
WO2012004714A2 (en) | 2010-07-09 | 2012-01-12 | Pfizer Limited | Chemical compounds |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6423717B1 (en) * | 1996-12-19 | 2002-07-23 | Smithkline Beecham P.L.C. | Sulphonamide derivatives, process for their preparation, and their use as medicaments |
-
2003
- 2003-11-06 AU AU2003295408A patent/AU2003295408A1/en not_active Abandoned
- 2003-11-06 WO PCT/US2003/035357 patent/WO2004043368A2/en not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6423717B1 (en) * | 1996-12-19 | 2002-07-23 | Smithkline Beecham P.L.C. | Sulphonamide derivatives, process for their preparation, and their use as medicaments |
US6599904B2 (en) * | 1996-12-19 | 2003-07-29 | Smithkline Beecham P.L.C. | Sulphonamide derivatives, process for their preparation, and their use as medicaments |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9233956B2 (en) | 2008-05-06 | 2016-01-12 | Novartis Ag | Benzene sulfonamide thiazole and oxazole compounds |
Also Published As
Publication number | Publication date |
---|---|
WO2004043368A2 (en) | 2004-05-27 |
AU2003295408A1 (en) | 2004-06-03 |
AU2003295408A8 (en) | 2004-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2415760A3 (en) | CCR-9 antagonists | |
MXPA03010158A (en) | Sulfonamides. | |
WO2004092135A3 (en) | Substituted benzosulphonamide as potentiators of glutamate receptors | |
SE0301653D0 (en) | Novel compounds | |
NO20034230L (en) | 1,2,3,4-tetrahydroisoquinoline derivatives as urotensin II receptor antagonists | |
NO20052493D0 (en) | Selected CGRP antagonists, processes for their preparation and their use as pharmaceutical compositions. | |
WO2004069152A3 (en) | Δ4,5 glycuronidase and uses thereof | |
WO2004033418A3 (en) | Sulfonylamino-acetic derivatives and their use as orexin receptor antagonists | |
WO2001044239A3 (en) | Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists | |
HRP20080564T3 (en) | Dihydrotetrabenazines and pharmaceutical compositions containing them | |
WO2004096798A3 (en) | Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and use of same as chemokine antagonists | |
WO2003000187A3 (en) | Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof | |
MY134136A (en) | Novel compounds comprising jak3 kinase inhibitors | |
IL175512A0 (en) | Methods of preparing aripiprazole crystalline forms | |
DK1499607T3 (en) | 4- (piperidyl and pyrrolidyl-alkyl-ureido) quinolines as urotensin II receptor antagonists | |
WO2004026836A8 (en) | 1-pyridin-4-yl-urea derivatives | |
TW200508197A (en) | Indolone-acetamide derivatives, processes for preparing them and their uses | |
WO2006133006A3 (en) | 1-methyl-1h-pyrazole-4-carboxamides useful as cancer chemotherapeutic agents | |
WO2004007664A3 (en) | Nucleic acid vectors | |
WO2002094856A3 (en) | Gpe analogs and peptidomimetics | |
WO2005030209A8 (en) | Pyridine derivatives and use thereof as urotensin ii antagonists | |
EP1556056A4 (en) | X-nitro compounds, pharmaceutical compositions thereof and uses therof | |
WO2002089740A3 (en) | Sulfonamides | |
WO2004043366A3 (en) | Sulfonamides | |
WO2004056832A3 (en) | Epothilone derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AU BA BB BR BZ CA CN CO CR CU DM DZ EC EG GD GE HR HU ID IL IN IS JP KP KR LC LK LR LT LV MA MG MK MN MX NO NZ OM PH PL RO SC SG TN TT UA US UZ VN YU ZA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |